GSA Capital Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $109K | Buy |
|
|||||
|
2023
Q2 | $201K | Buy |
|
|||||
|
2023
Q1 | $175K | Buy |
|
|||||
|
2022
Q4 | $92K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $960K | Buy |
|
|||||
|
2021
Q3 | $990K | Buy |
|
|||||
|
2021
Q2 | $681K | Buy |
|
|||||
|
2021
Q1 | $235K | Sell |
|
|||||
|
2020
Q4 | $1.67M | Buy |
|
|||||
|
2020
Q3 | $1.05M | Buy |
|
|||||
|
2020
Q2 | $219K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $192K | Sell |
|
|||||
|
2019
Q3 | $199K | Sell |
|
|||||
|
2019
Q2 | $487K | Buy |
|